Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1600 1611 1627 1645 1651 1653 1655
This examiner grants 9% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18491555 | CELL CULTURE COMPOSITIONS AND METHODS FOR POLYPEPTIDE PRODUCTION | Non-Final OA | GENENTECH, INC. |
| 16863187 | EQUOL-CONTAINING EXTRACT, METHOD FOR PRODUCTION THEREOF, METHOD FOR EXTRACTION OF EQUOL, AND EQUOL-CONTAINING FOOD | Final Rejection | OTSUKA PHARMACEUTICAL CO., LTD. |
| 18583611 | NON-INFECTIVE NASAL SYMPTOM MANAGEMENT COMPOSITIONS AND METHODS | Final Rejection | CMPD Licensing, LLC |
| 18554492 | COMPOSITION COMPRISING A EUKARYOTIC MICROALGAE OR AN EXTRACT THEREOF FOR USE IN THE TREATMENT OF A VIRAL DISEASE | Final Rejection | Philip Morris Products S.A. |
| 17730360 | BENZALDEHYDE PRODUCTION METHOD | Non-Final OA | AJINOMOTO CO., INC. |
| 17603695 | PLANT-DERIVED SCAFFOLDS FOR GENERATION OF SYNTHETIC ANIMAL TISSUE | Final Rejection | Wisconsin Alumni Research Foundation |
| 18134210 | PRODUCT COMPRISING PROBIOTICS AND ISOMALTULOSE AND METHOD OF ITS PRODUCTION | Non-Final OA | Bluestone Pharma GmbH |
| 17999858 | COMPOSITION FOR PURIFYING RESERVOIRS FROM CYANOBACTERIA AND GREEN ALGAE | Final Rejection | LYSTERRA LLC |
| 17774545 | PREPARATIONS FOR ENHANCED BIOCONTROL | Final Rejection | AREVO AB |
| 17719042 | INHALABLE IMATINIB FORMULATION | Final Rejection | Inaya Therapeutics, Inc. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy